| Tag | Content |
|---|
EnhancerAtlas ID | HS032-00609 |
Organism | Homo sapiens |
Tissue/cell | DLD1 |
Coordinate | chr2:70822980-70825000 |
TF binding sites/motifs | | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
| TP53 | MA0106.3 | chr2:70824222-70824240 | AACATGCCCAGGCATGTC | - | 9.39 | | TP53 | MA0106.3 | chr2:70824222-70824240 | AACATGCCCAGGCATGTC | + | 9.6 | | ZNF263 | MA0528.1 | chr2:70824963-70824984 | CTCTTTTTCCCTCTCTCCTTC | - | 6.19 |
|
| | Number of super-enhancer constituents: 2 | ID | Coordinate | Tissue/cell |
| SE_56248 | chr2:70822694-70827782 | u87 | | SE_67782 | chr2:70822694-70827782 | u87 |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 2 | Chromosome | Start | End |
| chr2 | 70823463 | 70823663 | | chr2 | 70823866 | 70823963 |
|
| | Number: 1 | ID | Chromosome | Start | End |
| GH02I070595 | chr2 | 70822998 | 70825124 |
|
Enhancer Sequence | ACAAACCTGC ACGTTCTGCA CATGTATCCA GAACTTAAAG TTAAAAAAAA ATAAGATCTG 60
GGGATCTAAT GTGCAGCATG GTGACAACAG TTAATAATGT TGTATTATAT ACTTGGAATT 120
AGCTAAGAGA GAGTTTATCT TAAGAGTTCT CACCAAAAAA AACAAAAATT AAAAAGGGAA 180
ACTATGTGAT TTGAGGGATG GATATGTTAA TTAACTTGAT TGTGGTAATT ATTTTACAAT 240
ACATACCTAT ATCAAATCTT CATGTTGTAC ACTTTAAATA TATACTTTAA ATATGGGAAA 300
AAAAAGAAAA GAAAGAAAAC CCTTCATGTC TATGCCTCCA ATGGGCTGAG TCTTCTCAAT 360
AGCCTTGGCA TTTGTTGGTG GCTAATTGAG GATGCCAAGG AGGGATTTCA CTACAGGGCT 420
TGGAACACAG CAGTACTTCC TTAAAATTAT CCTTAGAATC TCTTTCTCCT TCCAGCCGCT 480
GCTCAAATCC TACCCTCTTC CACCACCTCT TAAATCTTTT TCCTGCCTGC ATTTTCTTAC 540
ATAAAGCAAT CTACTACTGC CATCGGTTCA TTCACTCACC GGAACCTGTC TTGCCAGGAC 600
CTGACCTCAG CAGACTGAGT CATACCAGCA TCATCCTTGT TGGGGCCCAG GTCTGCATCC 660
CGCTTCCGGC CCCAGCCCCA CTGTTAGCTC CATCAGGTCC TCTGGGGCAC ACCAAGGAGG 720
CCGTTTTCTC TCCCTTTTTC TGAATTAGAT CCCCAGAAAC AAGACATCAG GCTTCCTGGG 780
GAAATCTAAT TTTGCTCATG AATTTGACCA TTCATTGTTG CTCAGTTACC TGTGCCCAGC 840
TCTTTCTGCC TTTTCAAACT GCACTCAGCT GTGCCCTTGA ATGAACTGGG GCAGAAGTCC 900
TTAGGTCCTG ATCACACATG CTGTTCCCAA CTTCCCTTCC CCTTGACACG CTGTGGTGAA 960
CTCTGAATTC CAGCACGTCT CCACTCTGCT GTAGAGCCTT TCTAGGGCTG GCAAGCATTC 1020
TGCCACAGAG CTGGTCTTTG TGGCTTTATG CCCACAGTAA TTACTAGGGC TGGGCCATGC 1080
AACCGTCTAA CCTCTTCAAT TTACAGCCTC CAGGATCTGC CACCCCTGTG GCATTTGGAG 1140
GGTGTCTAAC CACAGACCGG ACGTGCGTGG TAGCAGGTGG TCTGCTTGAT TGCTGGTCCT 1200
TCAGTGACCC CTCTGCTCTC CAGTGGCCAG ACAGGGATTC AGAACATGCC CAGGCATGTC 1260
TGCTACTGAC GTCCTCATCC ATGAAATTCC CAATATCTGC AGAAATTGTG TATTTGTACA 1320
TGTTGATTCT ATAATAAATA CTGAATCCCA GCCTGTACTG CAGAAAGGCT TCCTTAGCCT 1380
CTCAGTCTGG CTTACGTAAA GCAGCGTAAG TGTGATTCTC CATTTCACAC ACCGGGGCCC 1440
TTAACATTCC ATGCCCTCAT GGCTCTAATT CTGATTTTGG AACAGACCCC ACCATTTCCC 1500
TCTTTTTGAA GGTGACTTTG CAAGGATCAC ATAACTCCTG TTGGGCCAAC TTCCTTTCCC 1560
TTGTACTATG AGCATAACAA CTAGATGGTC AACCCGAAAG CTCATTCTTG TCACAGTTCT 1620
GGGGGGATCA GTTACCTGAA GCATACTCAG GTTGAAACCC CAGACAAACC TTACCAAATA 1680
TGATGTGAAC ATTCCAGTCT GCCCTGTAGA CCCTCACTAT GGTATCACAT CCCAATAAAC 1740
ACAAGCCCAC CTCAAAAGAA AAAAGAAAGA TTGATAAGTA ATGCAGGTCT TTACTTCTTG 1800
TAAACCCAGA AGAGAGGATT ACATAGCACG TCAGACAAAA ATATCTCTTA AAATCCTTTC 1860
TAAGCAATTC TTGTTATGCC CGAACTTTGA TTTCTCATCA GTTTCTTATG GTGAGTGCCC 1920
TATACCTAAA TCCCTCCAGT ATTTCCTCCA TTTCTTTGCC TCTCTGTTCC TTTCTTTCTT 1980
TCTCTCTTTT TCCCTCTCTC CTTCTGTCCT GTTATTACAT 2020
|
